These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 33540026

  • 61. Morphine brain pharmacokinetics at very low concentrations studied with accelerator mass spectrometry and liquid chromatography-tandem mass spectrometry.
    Sadiq MW, Salehpour M, Forsgard N, Possnert G, Hammarlund-Udenaes M.
    Drug Metab Dispos; 2011 Feb; 39(2):174-9. PubMed ID: 21059857
    [Abstract] [Full Text] [Related]

  • 62. Systemic and Brain Pharmacokinetics of Perforin Inhibitor Prodrugs.
    Gynther M, Pickering DS, Spicer JA, Denny WA, Huttunen KM.
    Mol Pharm; 2016 Jul 05; 13(7):2484-91. PubMed ID: 27266990
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. L-Type amino acid transporter 1 (lat1)-mediated targeted delivery of perforin inhibitors.
    Huttunen KM, Huttunen J, Aufderhaar I, Gynther M, Denny WA, Spicer JA.
    Int J Pharm; 2016 Feb 10; 498(1-2):205-16. PubMed ID: 26705152
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Anti-tumor effects of mAb against L-type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes.
    Ueda S, Hayashi H, Miyamoto T, Abe S, Hirai K, Matsukura K, Yagi H, Hara Y, Yoshida K, Okazaki S, Tamura M, Abe Y, Agatsuma T, Niwa SI, Masuko K, Masuko T.
    Cancer Sci; 2019 Feb 10; 110(2):674-685. PubMed ID: 30548114
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. Protein Expression and Functional Relevance of Efflux and Uptake Drug Transporters at the Blood-Brain Barrier of Human Brain and Glioblastoma.
    Bao X, Wu J, Xie Y, Kim S, Michelhaugh S, Jiang J, Mittal S, Sanai N, Li J.
    Clin Pharmacol Ther; 2020 May 10; 107(5):1116-1127. PubMed ID: 31664714
    [Abstract] [Full Text] [Related]

  • 74. Establishment and characterization of mammalian cell lines stably expressing human L-type amino acid transporters.
    Morimoto E, Kanai Y, Kim DK, Chairoungdua A, Choi HW, Wempe MF, Anzai N, Endou H.
    J Pharmacol Sci; 2008 Dec 10; 108(4):505-16. PubMed ID: 19075510
    [Abstract] [Full Text] [Related]

  • 75. A new treatment for human malignant melanoma targeting L-type amino acid transporter 1 (LAT1): a pilot study in a canine model.
    Fukumoto S, Hanazono K, Fu DR, Endo Y, Kadosawa T, Iwano H, Uchide T.
    Biochem Biophys Res Commun; 2013 Sep 13; 439(1):103-8. PubMed ID: 23954667
    [Abstract] [Full Text] [Related]

  • 76. L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier.
    Tomi M, Mori M, Tachikawa M, Katayama K, Terasaki T, Hosoya K.
    Invest Ophthalmol Vis Sci; 2005 Jul 13; 46(7):2522-30. PubMed ID: 15980244
    [Abstract] [Full Text] [Related]

  • 77. A Selective and Slowly Reversible Inhibitor of l-Type Amino Acid Transporter 1 (LAT1) Potentiates Antiproliferative Drug Efficacy in Cancer Cells.
    Huttunen KM, Gynther M, Huttunen J, Puris E, Spicer JA, Denny WA.
    J Med Chem; 2016 Jun 23; 59(12):5740-51. PubMed ID: 27253989
    [Abstract] [Full Text] [Related]

  • 78. L-Citrulline Level and Transporter Activity Are Altered in Experimental Models of Amyotrophic Lateral Sclerosis.
    Gyawali A, Gautam S, Hyeon SJ, Ryu H, Kang YS.
    Mol Neurobiol; 2021 Feb 23; 58(2):647-657. PubMed ID: 33000451
    [Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. Selective expression of the large neutral amino acid transporter at the blood-brain barrier.
    Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM.
    Proc Natl Acad Sci U S A; 1999 Oct 12; 96(21):12079-84. PubMed ID: 10518579
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.